Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases. [NA]

View source ↗

Summary

A clinical trial is evaluating whether quercetin intake benefits patients with fibrotic interstitial lung diseases, including idiopathic pulmonary fibrosis, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quercetin (quercetin)

Snippet

Sponsor: Katerina M. Antoniou | Conditions: Fibrotic Interstitial Lungs Diseases, Idiopathic Pulmonary Fibrosis (IPF) | NA | Status: RECRUITING